tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
with an average price target of $4.6. This is a potential upside of $4.6 (0%) from yesterday's end of day stock price of $0.
PhaseBio Pharmaceuticals's activity chart (see below) currently has 27 price targets and 21 ratings on display.
Analysts average stock forecasts to be materialized ratio is 2.86% with an average time for these price targets to be met of 21.14 days.
Most recent stock forecast was given by ANNABEL SAMIMY from STIFEL on 27-Sep-2022.
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Days to Hit Target
Performance score
Buy
$1
$0.96 (2400.00%)
$15
3 years 27 days ago
(27-Sep-2022)
0/2 (0%)
$0.74 (284.62%)
Buy
4 years 12 days ago
(12-Oct-2021)
0/1 (0%)
$6.27 (132.56%)
Buy
$15
$14.96 (37400.00%)
4 years 4 months 8 days ago
(16-Jun-2021)
0/3 (0%)
$11.02 (276.88%)
Buy
$10
$9.96 (24900.00%)
$12
5 years 2 months ago
(24-Aug-2020)
0/6 (0%)
$6.2 (163.16%)
Buy
$14
5 years 3 months 15 days ago
(09-Jul-2020)
1/5 (20%)
$7.98 (132.56%)
148
What is PHAS (PhaseBio Pharmaceuticals) average time for price targets to be met?
Which analyst has the current highest performing score on PHAS (PhaseBio Pharmaceuticals) with a proven track record?
Which analyst has the current lower performing score on PHAS (PhaseBio Pharmaceuticals) with a proven track record?
Which analyst has the most public recommendations on PHAS (PhaseBio Pharmaceuticals)?
Which analyst is the currently most bullish on PHAS (PhaseBio Pharmaceuticals)?
Which analyst is the currently most reserved on PHAS (PhaseBio Pharmaceuticals)?
